-
DE
ACPA (Anti-Citrullinated Protein Antibodies) are blood markers used for the early diagnosis of rheumatoid arthritis. Their detection is considered highly specific for this autoimmune disease.
ACPA (Anti-Citrullinated Protein Antibodies) are blood markers used for the early diagnosis of rheumatoid arthritis. Their detection is considered highly specific for this autoimmune disease.
ACPA stands for Anti-Citrullinated Protein Antibodies. These are autoantibodies produced by the immune system that mistakenly target the body's own proteins containing the amino acid derivative citrulline. Citrulline is formed through a chemical modification process called citrullination, in which the amino acid arginine within proteins is converted. In clinical practice, ACPA are most commonly detected using the Anti-CCP test (Anti-Cyclic Citrullinated Peptide).
ACPA are among the most important biomarkers for diagnosing rheumatoid arthritis (RA), a chronic inflammatory joint disease. Their presence in the blood is highly specific for RA and can be detected years before clinical symptoms appear, making ACPA a valuable tool for early detection.
ACPA are measured from a simple blood sample. In the laboratory, Anti-CCP antibodies are quantified using an immunological assay method called ELISA (Enzyme-Linked Immunosorbent Assay). Results are reported in units per milliliter (U/ml), and values above the laboratory-specific threshold are considered positive.
ACPA testing is part of the ACR/EULAR classification criteria for rheumatoid arthritis (2010). A positive ACPA result, combined with clinical signs such as joint swelling, morning stiffness, and elevated inflammatory markers (CRP, ESR), strongly supports the diagnosis.
In addition to ACPA, the rheumatoid factor (RF) is often measured when rheumatoid arthritis is suspected. ACPA are considered more specific than the rheumatoid factor, as RF can also be elevated in other conditions. The combination of both markers improves diagnostic accuracy.
A positive ACPA result carries not only diagnostic but also prognostic significance. Compared to ACPA-negative patients, those who test positive face a higher risk of:
Therefore, ACPA status influences both the choice of treatment and the assessment of long-term outcomes.
While ACPA themselves do not require direct treatment, their detection helps physicians initiate early and targeted therapy for rheumatoid arthritis. Treatment options include disease-modifying antirheumatic drugs (DMARDs) such as methotrexate, as well as biologics that specifically modulate immune system activity.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.